Skip to content
Harmonic Discovery logo

Harmonic Discovery

Harmonic Discovery is a YC Summer 2021 (S21) company. Based in New York, NY, USA; Remote. Team of 8.

  • AI-powered Drug Discovery
  • Biotech
  • Healthcare
  • Drug discovery

About Harmonic Discovery

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

Harmonic Discovery builds a computational-experimental platform to design drugs that hit multiple disease-causing proteins simultaneously. It uses machine learning to tune out toxic off-target interactions while tuning in secondary targets that improve efficacy and reduce resistance, replacing the conventional one-drug-one-protein design approach. Its focus is on complex diseases such as cancer and autoimmunity, where single-target drugs routinely fall short.

Go-to-market

Harmonic Discovery advances its own pipeline of multi-targeted therapeutics and pursues external partnerships, targeting biopharma collaborators and research institutions that need precision pharmacology capabilities beyond what standard drug discovery tools provide.

From the Y Combinator listing

How Harmonic Discovery describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Multi-targeted therapeutics to treat complex diseases

We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
New York, NY, USA; Remote
Team size
8
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works